SCHEMBL18616529

SCHEMBL18616529

N#CC1(NC(=O)C2(NC(=O)c3cc4ccc(-c5ccc(C6(O)COC6)cc5)nc4o3)CCCCC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 14/20 0.43
▸ CTSS P25774 17/20 0.34
▸ CTSB P07858 16/20 0.34
▸ CTSK P43235 6/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18616515 0.88 CTSL (0.41) CTSLCTSSCTSBCTSK
SCHEMBL18615883 0.86 CTSL (0.45) CTSLCTSSCTSBCTSK
SCHEMBL18616609 0.86 CTSL (0.45) CTSLCTSSCTSBCTSK
SCHEMBL20341765 0.85 CTSL (0.44) CTSLCTSSCTSBCTSK
SCHEMBL23810251 0.84 CTSL (0.43) CTSLCTSSCTSBCTSK
SCHEMBL18616543 0.84 CTSL (0.43) CTSLCTSSCTSBCTSK
SCHEMBL18615930 0.79 CTSL (0.46) CTSLCTSSCTSBCTSK
SCHEMBL18616498 0.78 CTSL (0.38) CTSLCTSSCTSBCTSK
SCHEMBL18615884 0.78 CTSL (0.44) CTSLCTSSCTSBCTSK
SCHEMBL18616522 0.78 CTSL (0.42) CTSLCTSSCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342765-B1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-09-15 — — EP disclosed
EP-3342765-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2018-07-04 — — EP disclosed
WO-2017036357-A1 CATHEPSIN K INHIBITOR AND APPLICATION THEREOF 广东东阳光药业有限公司 2017-03-09 — — WO disclosed
Send feedback